BackCantel Medical Overview

Cantel Medical Profit Margin

Cantel Medical (CMD) has a profit margin of 4.57%, below the Healthcare sector average of 14.34%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

6.73%
0.95% YoY

As of Apr 2021

Annual Profit Margin (TTM)

4.57%
66.27% YoY

Trailing 12 months ending Apr 2021

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Cantel Medical (CMD) FAQ

Cantel Medical (CMD) currently reports a profit margin of 4.57% as of April 2021. That compares with 2.75% in the prior-year period — up 66.3% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Cantel Medical's profit margin history and peer comparisons.

Cantel Medical's profit margin increased from 2.75% to 4.57% — a 66.3% year-over-year increase (period ending April 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cantel Medical's profit margin of 4.57% is lower than the Healthcare sector average of 14.34%. That is roughly 68.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Cantel Medical's current 4.57% should be judged against Healthcare norms (sector average: 14.34%) and against CMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 4.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Cantel Medical, and consider following CMD for alerts when major investors trade the stock.